Research
BTIG Upgrades AVITA Medical to Buy From Neutral, $7 Price Target
$RCEL
2 stories mentioning RCELUpdated 47d ago
Every FINWIRES story that references RCEL, newest first.
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
AVITA Medical's (RCEL) board appointed Cary Vance as president and chief executive officer, effective immediately after serving as CEO on an interim basis since October, the company said Thursday.The board also named Jan Stern Reed as chairman, with immediate effect, AVITA Medical said.Price: $4.33, Change: $+0.10, Percent Change: +2.36%